Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Liver Neoplasms × brivanib × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 2 Liver Neoplasms 1

Interventions

Sorafenib 8 durvalumab 4 Cisplatin 4 Gemcitabine 3 Ethiodized Oil 3 Doxorubicin 3 Chemotherapy, Adjuvant 3 Bevacizumab 3 tremelimumab 2 phosphomannopentaose sulfate 2 Watchful Waiting 2 Talaporfin 2 Radiofrequency Ablation 2 Oxaliplatin 2 Nivolumab 2 Folfox protocol 2 Capecitabine 2 Analgesia, Patient-Controlled 2 sodium thiosulfate 1 seocalcitol 1 parecoxib 1 nolatrexed 1 linifanib 1 lenvatinib 1 ferumoxides 1 ferric carboxymaltose 1 contrast agent BR1 1 cabozantinib 1 brivanib 1 atezolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00825955 2019-10-09

BRISK PS

Bristol-Myers Squibb

Phase 3 Completed

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡